
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Prepared to a prescriber's order for one patient. Not FDA-approved.
This is a compounded oral liquid containing indomethacin, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.
These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.
FDA-approved products containing indomethacin are listed in capsule, suppository, injection and suspension forms.
Liquid bases can be aqueous or nonaqueous, and USP <795> classifies the preparation by its water activity. Aqueous preparations carry shorter default beyond-use dates than nonaqueous ones. The date printed on the label is the one to follow.
Indomethacin is a nonsteroidal anti-inflammatory drug (NSAID) that compounding pharmacies prepare as oral liquids, capsules, suppositories and topical preparations by prescription.
Indomethacin is a nonsteroidal anti-inflammatory drug. It blocks the cyclooxygenase enzymes COX-1 and COX-2, lowering prostaglandins, chemical messengers that drive pain, swelling and fever. Manufactured forms include immediate-release and extended-release capsules, an oral suspension, Indocin rectal suppositories and an injection. Indocin suppositories (Zyla) are FDA-approved for moderate to severe rheumatoid arthritis, ankylosing spondylitis and osteoarthritis, acute painful shoulder (bursitis or tendinitis) and acute gouty arthritis. Indomethacin for Injection (Fresenius Kabi) is approved to close a hemodynamically significant patent ductus arteriosus in premature infants. A prescriber may order indomethacin compounded in a strength, vehicle or dosage form not made commercially, such as a topical preparation or a suppository in a different base. Compounded preparations are not FDA-approved and require a prescription.
Indomethacin carries the FDA boxed warning for NSAIDs: an increased risk of heart attack and stroke, which can be fatal, and of serious stomach and intestinal bleeding, ulcers and perforation. It must not be used around coronary artery bypass graft surgery. Do not use it if you are allergic to indomethacin or have had asthma, hives or other allergic reactions after aspirin or other NSAIDs; the suppositories should not be used with proctitis or recent rectal bleeding. The label also warns about liver injury, high blood pressure and serious skin reactions. Blood thinners, aspirin, SSRIs and SNRIs raise bleeding risk, it can blunt blood pressure medicines, and it should not be combined with triamterene. During pregnancy, use only as your prescriber directs: the label advises limiting use from about 20 weeks and avoiding it from about 30 weeks. Small amounts pass into breast milk, according to LactMed. For black stools, chest pain or swelling, talk to your prescriber or pharmacist right away.
Indomethacin is a nonselective COX inhibitor and potent inhibitor of prostaglandin synthesis. Oral capsules are virtually completely bioavailable, and rectal absorption is more rapid than oral. It is about 99 percent protein bound, undergoes appreciable enterohepatic circulation, and crosses the blood-brain barrier and placenta. The Indocin label gives a mean half-life of about 4.5 hours; StatPearls describes it as highly variable. Labeled indications: rheumatoid arthritis, ankylosing spondylitis, osteoarthritis, acute painful shoulder and acute gout (Indocin suppositories), and patent ductus arteriosus closure in premature infants (Indomethacin for Injection). StatPearls lists off-label uses including rectal use to reduce post-ERCP pancreatitis, acute pericarditis, tocolysis in preterm labor and indomethacin-responsive headaches such as paroxysmal hemicrania and hemicrania continua. Dosing per prescriber. Monitor for GI bleeding, blood pressure, liver tests if symptoms appear, renal function in high-risk patients, and CBC and chemistry with long-term use; the label advises watching for lithium and methotrexate toxicity and checking serum digoxin levels when coadministered. Avoid NSAIDs at about 30 weeks gestation and later because of premature ductus closure. Indomethacin is not a controlled substance.
Shake the bottle if your label says to. Measure each dose with the oral syringe or dosing cup the pharmacy gave you, never a kitchen spoon. Give the liquid slowly into the mouth. Rinse the syringe with water after each use. Call the pharmacy if you are unsure how to measure.
Storage depends on the vehicle. Water-based liquids with a preservative usually carry a USP <795> beyond-use date of up to 35 days; without a preservative they are kept refrigerated for up to 14 days. Oil-based (nonaqueous) oral liquids may carry up to 90 days. Your label states whether to refrigerate and the beyond-use date. Keep out of reach of children and discard after that date.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take orally